A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Peter O'Toole Peter O'Toole Peter O'Toole University of York, UK Anna C Obenauf Anna C Obenauf Anna C Obenauf Research Institute of Molecular Pathology (IMP), AT John Oliver John Oliver John Oliver Vice President, Research & Development, Nabsys, US Kris Olson Kris Olson Kris Olson University of Utah, US Christine Orengo Christine Orengo Christine Orengo University College London, UK Olga Ornatsky Olga Ornatsky Olga Ornatsky Principle Scientist and Co-founder of DVS Sciences, Fluidigm, US Tobias Ost Tobias Ost Tobias Ost R&D Manager Cambridge Epigenetix, UK Oliver Otto Oliver Otto Oliver Otto CEO Zellmechanik Dresden, DE Marvin Y. Ouyang Marvin Y. Ouyang Marvin Y. Ouyang Vice President, Technologies, Cyagen Biosciences Inc., US John Oxford John Oxford John Oxford Queen Mary College, London, UK
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Peter O'Toole Peter O'Toole Peter O'Toole University of York, UK Anna C Obenauf Anna C Obenauf Anna C Obenauf Research Institute of Molecular Pathology (IMP), AT John Oliver John Oliver John Oliver Vice President, Research & Development, Nabsys, US Kris Olson Kris Olson Kris Olson University of Utah, US Christine Orengo Christine Orengo Christine Orengo University College London, UK Olga Ornatsky Olga Ornatsky Olga Ornatsky Principle Scientist and Co-founder of DVS Sciences, Fluidigm, US Tobias Ost Tobias Ost Tobias Ost R&D Manager Cambridge Epigenetix, UK Oliver Otto Oliver Otto Oliver Otto CEO Zellmechanik Dresden, DE Marvin Y. Ouyang Marvin Y. Ouyang Marvin Y. Ouyang Vice President, Technologies, Cyagen Biosciences Inc., US John Oxford John Oxford John Oxford Queen Mary College, London, UK
Olga Ornatsky Olga Ornatsky Olga Ornatsky Principle Scientist and Co-founder of DVS Sciences, Fluidigm, US
Marvin Y. Ouyang Marvin Y. Ouyang Marvin Y. Ouyang Vice President, Technologies, Cyagen Biosciences Inc., US
